- Supported exchanges /
- PINK /
- SBLOF.PINK
Shin Nippon Biomedical Laboratories, Ltd. (SBLOF PINK) stock market data APIs
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies. The company also engages in the investigator brochure preparation support, clinical trial protocol creation support, clinical trial medical institution, investigational drug allocation, clinical trial request/contract, monitoring, quality management, data management, statistical analysis work, comprehensive report creation support, electronic application support, regulatory affairs consulting, and creating informed consent documents support services. In addition, it provides site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of vaccines and therapeutic drugs, antibody drugs, nucleic acid drugs, peptide drugs, gene therapy, and regenerative medicines. Further, the company is involved in the operates geothermal power generation; operates hotel accommodation facilities; and wellbeing businesses, as well as provides cleaning, clerical work, and welfare services. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.
Shin Nippon Biomedical Laboratories, Ltd. Financial Data Overview
16.97 | |
16.97 | |
- | |
16.97 | |
16.97 | |
16.8413-16.97 | |
706 M | |
18.4457 | |
41 632 K | |
26 195 M | |
0.0188 | |
0 | |
-0.032 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Shin Nippon Biomedical Laboratories, Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 26 195 M
- EBITDA 4 725 M
- Earnings Per Share 0.92
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Shin Nippon Biomedical Laboratories, Ltd. Earnings via APIs
- Latest Release 2024-08-05
- EPS/Forecast NaN
Get Shin Nippon Biomedical Laboratories, Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: